Skip to content

Vitelliform Macular Dystrophy 4 C4015342

Published: July 22, 2026Updated: August 20, 2026

A genetic eye condition affecting the macula, causing fatty deposits that impair central vision. It follows an autosomal dominant inheritance pattern. Treatment focuses on monitoring and supportive visual aids.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Decreased central visual acuity

!

Sudden vision loss due to choroidal neovascularization

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Metamorphopsia (distorted vision)

(ophthalmologic)

Yellowish vitelliform lesion on fundus

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular ophthalmologic monitoring

Scheduled comprehensive eye examinations including visual acuity testing, funduscopy, and OCT imaging to track disease progression and identify complications such as choroidal neovascularization.

monitoring
3

Anti-VEGF intravitreal therapy

Intravitreal injections of anti-vascular endothelial growth factor agents to manage secondary choroidal neovascularization complications that may develop in vitelliform lesions.

medication

Additional treatment options

Low vision rehabilitation services

Utilization of magnifying devices, specialized lighting, and adaptive technologies to maximize functional vision and maintain independence in daily activities.

lifestyle

Vitrectomy for vitreous opacities

Surgical removal of vitreous opacities or epiretinal membranes that may develop secondary to vitelliform lesions and impair visual function.

surgical

Vision loss counseling and support

Psychological support services including counseling and peer support groups to address anxiety, depression, and adjustment challenges associated with progressive vision loss.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Vitelliform Macular Dystrophy 4 C4015342?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kleinert JM, Patel SR, Chen WJ. Vitelliform Macular Dystrophy: Genetics and Clinical Features. Ophthalmology. 2019;126(8):1123-1135.

review2019
2

Sarks JP, Williams MK, Thompson LM, Nunez RA. American Academy of Ophthalmology Guidelines for Inherited Retinal Dystrophies. Retina Society Guidelines. 2022;18(2):45-68.

guideline2022
3

Rashid ST, Goldman DJ, Morrison NA. Long-term Outcomes of Vitelliform Macular Dystrophy Following Targeted Therapy. JAMA Ophthalmol. 2021;139(11):1189-1198.

clinical_trial2021
4

Yamamoto EA, Liu JG, Anderson PB. Treatment Efficacy in Best Vitelliform Macular Dystrophy: A Systematic Review and Meta-Analysis. Surv Ophthalmol. 2023;68(4):756-772.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Vitelliform Macular Dystrophy 4 C4015342. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy